Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2022-05-15
2022-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
NCT05999266
The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
NCT04779164
Investigation of Predisposing Factors Affecting Pain in Patients With Knee Osteoarthritis
NCT05238857
Ultrasound Imaging of Quadriceps Muscle in Patients With Knee Osteoarthritis
NCT04660071
Total Knee Arthroplasty and Clinical Findings
NCT04481711
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: This study is designed as a prospective, cross-sectional trial. 90 participants aged between 50-65 years with knee osteoarthritis(OA) and at least 50 participants without any symptom for knee OA are included in the study in accordance with the inclusion criteria. Participants' demographic characteristics will be evaluated, and ultrasonographic measurement will be performed for measuring femoral cartilage thickness. Visual Analog scale will be used for pain severity and Western Ontario and McMaster Universities Osteoartrit index (WOMAC) will be used for assessing functionality of the patients. Also hematologic parameters(neutrophils, leucocytes, lymphocytes, platelet, CRP, erythrocyte sedimentation rate) will be evaluated for investigating the inflammation. The relationship between femoral cartilage thickness and inflammatory parameters, pain severity and functionality in knee osteoarthritis will be analysed for both group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
knee osteoarthritis
ultrasonographic measurement for femoral cartilage thickness VAS for pain severity WOMAC for functionality
ultrasonographic measurement for femoral cartilage thickness VAS for pain severity WOMAC for functionality
ultrasonographic measurement for femoral cartilage thickness VAS for pain severity WOMAC for functionality
healthy control
ultrasonographic measurement for femoral cartilage thickness VAS for pain severity WOMAC for functionality
ultrasonographic measurement for femoral cartilage thickness VAS for pain severity WOMAC for functionality
ultrasonographic measurement for femoral cartilage thickness VAS for pain severity WOMAC for functionality
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasonographic measurement for femoral cartilage thickness VAS for pain severity WOMAC for functionality
ultrasonographic measurement for femoral cartilage thickness VAS for pain severity WOMAC for functionality
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged between 50-65 years
* volunteer to participate in the study
Exclusion Criteria
* moderate to severe dementia or mental retardation, which may cause limitations in examination, testing and treatment
* refusal to participate in the study
* pprevious total knee prosthesis surgery
* secondary osteoarthritis
50 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merve Damla Korkmaz
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Merve D. Korkmaz, M.D.
Role: PRINCIPAL_INVESTIGATOR
Kanuni Sultan Suleyman Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Kucukcekmece, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KAEK/2022.05.103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.